Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Growth Horm IGF Res. 2014 May 17;24(4):142–149. doi: 10.1016/j.ghir.2014.04.006

Table 1.

Study Population Characteristics (n=558)

Demographic and Behavioral Variables Mean ± SD or n (%)
 Age, yr 56 ± 7
 White / Caucasian (versus Other) 546 (97.9)
 Postmenopausal 436 (78.1)
 Current hormone use* 183 (32.8)
 Current smoker 62 (11.2)
 Body mass index (kg/m2) 25.1 ± 4.3
 Physical activity, MET-hrs/week 15.0 ± 17.5
Daily Energy and Macronutrient Intake
 Energy intake, kcal 1766 ± 494
 Alcohol intake, % kcal 2.1 ± 3.8
 Carbohydrate, %kcal 50.4 ± 8.6
 Protein, %kcal 18.9 ± 3.2
 Dairy protein, % kcal 3.7 ± 1.9
 Total fat, %kcal 31.2 ± 6.0
 Saturated fat, % kcal 10.5 ± 2.5
 Trans fat, % kcal 1.5 ± 0.6
 Monounsaturated fat, %kcal 12.0 ± 2.7
 Polyunsaturated fat, %kcal 5.9 ± 1.6
Biomarkers
 IGF-I, total, ng/mL 152.3 ± 50.7
 IGF-I, free, ng/mL 0.5 ± 0.3
 IGFBP-1, ng/mL 41.5 ± 28.1
 IGFBP-2, ng/mL 593.2 ± 352.0
 IGFBP-3, ng/mL 4,676.8 ± 1,001.7
 CRP, mg/dL 1.4 ± 3.6
 Adiponectin, μg/mL 18.3 ± 7.4
 Resistin, ng/mL 17.5 ± 11.9
 Leptin, ng/mL 19.5 ± 13.0
 Soluble leptin receptor (sOB-R), ng/mL 34.9 ± 11.3
 Insulin, μU/mL 6.8 ± 5.3
 HbA1C, % 5.2 ± 0.4
 IL-18, pg/mL 300.7 ± 187.3
*

Current hormone therapy (HT) (versus past/never), body mass index (BMI)